FibroGen (FGEN) Misses Q1 EPS by 26c

FibroGen (NASDAQ: FGEN) reported Q1 EPS of ($0.78), $0.26 worse than the analyst estimate of ($0.52). Revenue for the quarter came in at $16.3 million versus the consensus estimate of $34 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Wells Fargo cuts Netflix rating on engagement risk, weak slate
• Redburn upgrades Southwest, stays bullish on Delta and United